Riskpilot← Back to searchSign inGet full accessLive2care AB
ABActiveOrg 5569662918Sveavägen 49Medical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
SEK 0
EBITDA margin
—
-339% vs 2023
Equity ratio
88.0%
Financial strength
Net profit 2024
SEK -69K
-321% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -69K | -339% |
| Net profit | SEK -69K | -321% |
| Total assets | SEK 68K | -20% |
| Equity | SEK 60K | -24% |
| Employees | 1 | — |
Legal name
Live2care AB
Org number
5569662918
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 mars 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård samt tillhandahålla tjänster inom estetisk hudvård och injektionsbehandlingar. Bolaget ska även bedriva handel med värdepapper samt därmed förenlig verksamhet.
Address
Sveavägen 49
Email
lovisa.tjulander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 30 | 133 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −46 |
| EBITDA | 19 | 118 | −16 | −16 | −69 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 19 | 118 | −16 | −16 | −69 |
| Net financials | — | — | −0 | −1 | 0 |
| Profit before tax | 19 | 118 | −16 | −16 | −69 |
| Tax | −2 | −24 | — | — | — |
| Net profit | 17 | 94 | −16 | −16 | −69 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 184 | 314 | 125 | 85 | 68 |
| Equity | 176 | 270 | 94 | 78 | 60 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 8 | 44 | 30 | 6 | 8 |
| Total debt | 8 | 44 | 30 | 6 | 8 |
EBITDA margin
-6854800.0%
This company
15.8%
Market median
-43384910% vs market
20202024
Equity ratio
88.0%
This company
38.2%
Market median
+130% vs market
20202024
Return on equity
-114.8%
This company
18.4%
Market median
-724% vs market
20202024
Net profit margin
-6851900.0%
This company
8.1%
Market median
-84591458% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GR Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Live2care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gun Rut Marta Lovisa Nordahl | Chief Executive Officer | 0 companies |
| Tommy Nordahl | Deputy Board Member | 0 companies |